1. Home
  2. ASMB vs FMN Comparison

ASMB vs FMN Comparison

Compare ASMB & FMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • FMN
  • Stock Information
  • Founded
  • ASMB 2005
  • FMN 2002
  • Country
  • ASMB United States
  • FMN United States
  • Employees
  • ASMB N/A
  • FMN N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • FMN Investment Managers
  • Sector
  • ASMB Health Care
  • FMN Finance
  • Exchange
  • ASMB Nasdaq
  • FMN Nasdaq
  • Market Cap
  • ASMB 84.5M
  • FMN 86.2M
  • IPO Year
  • ASMB 2010
  • FMN N/A
  • Fundamental
  • Price
  • ASMB $10.03
  • FMN $10.47
  • Analyst Decision
  • ASMB Strong Buy
  • FMN
  • Analyst Count
  • ASMB 3
  • FMN 0
  • Target Price
  • ASMB $33.00
  • FMN N/A
  • AVG Volume (30 Days)
  • ASMB 37.9K
  • FMN 22.8K
  • Earning Date
  • ASMB 05-07-2025
  • FMN 01-01-0001
  • Dividend Yield
  • ASMB N/A
  • FMN 3.86%
  • EPS Growth
  • ASMB N/A
  • FMN N/A
  • EPS
  • ASMB N/A
  • FMN N/A
  • Revenue
  • ASMB $28,520,000.00
  • FMN N/A
  • Revenue This Year
  • ASMB $10.82
  • FMN N/A
  • Revenue Next Year
  • ASMB N/A
  • FMN N/A
  • P/E Ratio
  • ASMB N/A
  • FMN N/A
  • Revenue Growth
  • ASMB 298.16
  • FMN N/A
  • 52 Week Low
  • ASMB $7.75
  • FMN $9.09
  • 52 Week High
  • ASMB $19.93
  • FMN $11.31
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 48.99
  • FMN 39.04
  • Support Level
  • ASMB $7.90
  • FMN $10.12
  • Resistance Level
  • ASMB $10.36
  • FMN $10.99
  • Average True Range (ATR)
  • ASMB 0.85
  • FMN 0.14
  • MACD
  • ASMB 0.21
  • FMN -0.02
  • Stochastic Oscillator
  • ASMB 86.04
  • FMN 40.91

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About FMN Federated Hermes Premier Municipal Income Fund

Federated Hermes Premier Municipal Income Fund is a United States-based diversified, closed-end management investment company. The investment objective of the fund is to provide current income exempt from federal income tax, including the federal alternative minimum tax by investing in long-term, tax exempt municipal bonds diversified among states, sectors and issuers. Its portfolio of investments comprises different sectors such as hospitals, toll road, senior care, airport, tobacco, and other sectors.

Share on Social Networks: